Posted March 27, 2024

DSH Hospitals’ 340B Profit Often Exceeds Charity Care Spending

Under the 340B Drug Pricing Program (“340B Program”), certain types of healthcare facilities
and providers (“covered entities”) can purchase medications at a discounted price.
Covered entities include qualifying hospitals and clinics receiving certain types of Federal
grants. Total purchases at the discounted 340B price were $54 billion in 2022, 87 percent
of which were made by hospitals. Disproportionate Share Hospitals (DSHs) specifically
accounted for $42 billion (78 percent) of program sales.

Scroll to Top